Sagimet Biosciences Inc. (SGMT) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Sagimet Biosciences Inc. (SGMT) Earnings Overview
As of June 22, 2026, Sagimet Biosciences Inc. (SGMT) reported trailing twelve-month net income of -$44M, reflecting -9.0% year-over-year growth. The company earned $-1.34 per diluted share over the past four quarters.
Looking at the long-term picture, SGMT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$11M in fiscal 2020.
Sagimet Biosciences Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MDGL (-$309M net income, -30.1% margin), AKBA (-$21M net income, -2.3% margin), HALO ($349M net income, 22.7% margin), SGMT has comparable earnings metrics. Compare SGMT vs MDGL →
SGMT Earnings vs Peers
Earnings metrics vs comparable public companies
SGMT Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$51M | -12.0% | -$57M | $-1.58 | - | - |
| 2024 | -$46M | -63.5% | -$54M | $-1.45 | - | - |
| 2023 | -$28M | +8.6% | -$31M | $-1.53 | -1393.8% | -1537.0% |
| 2022 | -$30M | -24.8% | -$31M | $-1.38 | - | - |
| 2021 | -$24M | -115.0% | -$24M | $-1.10 | - | - |
| 2020 | -$11M | +20.3% | -$11M | $-0.51 | - | - |
| 2019 | -$14M | - | -$14M | $-0.64 | - | - |
Download Data
Export SGMT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SGMT — Frequently Asked Questions
Quick answers to the most common questions about buying SGMT stock.
What is SGMT earnings per share (EPS)?
SGMT trailing twelve-month (TTM) diluted EPS is $-1.34, reflecting -9.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Sagimet Biosciences Inc.'s net income?
Sagimet Biosciences Inc. (SGMT) trailing twelve-month net income is $-44M as of 2025. Earnings declined -9.0% year-over-year.
Is SGMT profitable?
SGMT is not currently profitable on a TTM basis, reporting a net loss of $-44M. Net margin is N/A. Investors should monitor for a return to profitability.
What is SGMT's earnings growth rate?
SGMT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are SGMT's profit margins?
Sagimet Biosciences Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -38.2%.
Is SGMT growing earnings?
SGMT earnings are declining — EPS fell -9.0% year-over-year. TTM net income dropped to $-44M. This contrasts with the 5-year CAGR of N/A.
What was SGMT's best earnings year?
Sagimet Biosciences Inc.'s highest annual net income on record is $-11M, achieved in fiscal year 2020. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were SGMT's earnings last quarter?
SGMT's most recent reported quarter was Q1 2026. Net income was $-11M with diluted EPS of $-0.33. For a full breakdown of all quarters, see the quarterly earnings table on this page.